Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-19-008098
Filing Date
2019-02-14
Accepted
2019-02-14 16:01:50
Documents
3
Group Members
DAVID E. SHAW

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tv512935_sc13ga.htm SC 13G/A 44615
2 EXHIBIT 1 tv512935_ex-1.htm EX-99.1 6298
3 EXHIBIT 2 tv512935_ex-2.htm EX-99.2 4436
  Complete submission text file 0001144204-19-008098.txt   56977
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Subject) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-48577 | Film No.: 19605884
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036
Business Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036 2124780000
D. E. SHAW & CO, L.P. (Filed by) CIK: 0001009268 (see all company filings)

EIN.: 133695715 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A